Vicente J, Salvador J, Laguna P, Algaba F, Caffaratti J
IUNA-Fundación Puigvert, Servicio de Urología, Barcelona, España.
Arch Esp Urol. 1990;43 Suppl 2:125-30.
Based on the treatment with Nd-YAG laser of 109 superficial bladder tumors (52 initial cases and 57 recurrences), herein we report on its indications, technical aspects, and clinical advantages. In order to evaluate the difference between laser therapy and TUR, three groups were studied to compare both techniques. 1) We evaluated the incidence of tumor recurrence in 27 cases submitted to laser therapy and 26 cases submitted to TUR. At 2 years no significant differences were observed relative to tumor recurrence or progression for both groups. 2) We evaluated bladder parietal involvement for each technique. All but one of 109 cases that had been submitted to laser therapy had preserved initial bladder capacity. Biopsies performed in areas post-laser therapy (31) and post-TUR (24), and with the resector loop in 22 cases, revealed no histologic difference between both groups (replacement fibrosis and elastic fibers). 3) We evaluated the incidence of urethral stenosis after laser therapy (22) and TUR (55). Urethral stricture was significantly lower (4.5%) for those treated with laser than for those treated by TUR (16.3%). On the basis of the overall (109 cases) and the partial (study groups) results, we consider laser treatment of superficial bladder tumors to be limited to single, less than 2-3 cms, or small, multiple initial or recurrent neoformations.
基于对109例浅表性膀胱肿瘤(52例初发病例和57例复发病例)进行钕钇铝石榴石激光治疗,我们在此报告其适应症、技术要点及临床优势。为评估激光治疗与经尿道膀胱肿瘤切除术(TUR)之间的差异,我们研究了三组病例以比较这两种技术。1)我们评估了27例接受激光治疗的病例和26例接受TUR治疗的病例的肿瘤复发率。在2年时,两组在肿瘤复发或进展方面未观察到显著差异。2)我们评估了每种技术对膀胱壁的累及情况。接受激光治疗的109例病例中,除1例之外,其余病例均保留了初始膀胱容量。对激光治疗后区域(31处)和TUR后区域(24处)进行活检,并对22例病例使用切除环进行活检,结果显示两组之间在组织学上无差异(均为替代性纤维化和弹性纤维)。3)我们评估了激光治疗(22例)和TUR(55例)后尿道狭窄的发生率。接受激光治疗者的尿道狭窄发生率(4.5%)显著低于接受TUR治疗者(16.3%)。基于总体(109例病例)和部分(研究组)结果,我们认为激光治疗浅表性膀胱肿瘤仅限于单个、直径小于2 - 3厘米的肿瘤,或小型、多发的初发或复发新生物。